Treating Acute Pancreatitis With Dabigatran, a Pilot Study
Latest Information Update: 02 Sep 2022
At a glance
- Drugs Dabigatran etexilate (Primary)
- Indications Pancreatitis
- Focus Adverse reactions
Most Recent Events
- 30 Aug 2022 Status changed from recruiting to discontinued.
- 30 Mar 2022 Planned primary completion date changed from 28 Feb 2022 to 28 Jul 2022.
- 30 Mar 2021 Planned End Date changed from 30 Aug 2021 to 30 Aug 2022.